Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: A systematic review and meta-analysis of comparative studies

BJU International

Volumn 113, Issue 5 B, 2014, Pages

  Bi, Liangkuan ^a   Huang, Hai ^a   Fan, Xinxiang ^a   Li, Kaiwen ^a   Xu, Kewei ^a   Jiang, Chun ^a   Liu, Hao ^a   Dong, Wen ^a   Zhang, Simin ^a   Yang, Xiangyun ^a   Lin, Tianxin ^a   Huang, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cystectomy; Lymph node dissection; Meta analysis; Systematic review; Urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CYSTECTOMY; EXTENDED PELVIC LYMPH NODE DISSECTION; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; META ANALYSIS; NON EXTENDED PELVIC LYMPH NODE DISSECTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMATIC REVIEW; BLADDER TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; PELVIS; REVIEW; TUMOR RECURRENCE;

CYSTECTOMY; LYMPH NODE DISSECTION; META-ANALYSIS; SYSTEMATIC REVIEW; URINARY BLADDER NEOPLASMS;

CYSTECTOMY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PELVIS; URINARY BLADDER NEOPLASMS;

EID: 84902309933     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12371     Document Type: Article

References (43)

1. Jemal A, Siegel R, Xu J et al. Cancer statistics. CA Cancer J Clin 2010; 60: 277-300
2. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92 (Pubitemid 46359643)
3. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
4. Herr HW, Faulkner JR, Grossman HB et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004; 22: 2781-9 (Pubitemid 41079895)
5. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol 2003; 169: 946-50 (Pubitemid 36188131)
6. May M, Herrmann E, Bolenz C et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 2011; 18: 2018-25
7. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700
8. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting.Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12 (Pubitemid 30214957)
9. Herr H, Lee C, Chang S et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 2004; 171: 1823-7 (Pubitemid 38501012)
10. Dorin RP, Daneshmand S, Eisenberg MS et al. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 2011; 60: 946-52
11. Stein JP. Lymphadenectomy in bladder cancer: how high is "high enough. Urol Oncol 2006; 24: 349-55 (Pubitemid 43963403)
12. Howick J, Chalmers I, Glasziou P et al. The Oxford 2011 Levels of Evidence. 2011 Oxford Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed 23 February 2013
13. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-34 (Pubitemid 28562978)
14. Novara G, Ficarra V, Mocellin S et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 2012; 62: 382-404
15. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
16. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004; 171: 139-44 (Pubitemid 37549109)
17. Svatek R, Zehnder P. Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer. Curr Urol Rep 2012; 13: 115-21
18. Brossner C, Pycha A, Toth A et al. Does extended lymphadenectomy increase morbidity in association with radical cystectomy? Journal Fur Urologie Und Urogynakologie 2004; 11: 15-7
19. Zehnder P, Studer UE, Skinner EC et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 2011; 186: 1261-8
20. Abol-Enein H, Tilki D, Mosbah A et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011; 60: 572-7
21. Dhar NB, Klein EA, Reuther AM et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873-8
22. Holmer M, Bendahl PO, Davidsson T et al. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol 2009; 27: 521-6
23. Jensen JB, Ulhoi BP, Jensen KME. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 2012; 19: 39-47
24. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9; discussion 20
25. Simone G, Papalia R, Ferriero M et al. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol 2012; 20: 390-7
26. Marnitz S, Kohler C, Affonso RJ et al. Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. Oncology 2012; 83: 346-53
27. Palaia I, Musella A, Bellati F et al. Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer. Gynecol Oncol 2012; 126: 78-81
28. Ramirez PT, Jhingran A, Macapinlac HA et al. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 2011; 117: 1928-34
29. Herr HW, Bochner BH, Dalbagni G et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-8 (Pubitemid 34132073)
30. Koppie TM, Vickers AJ, Vora K et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006; 107: 2368-74 (Pubitemid 44748519)
31. Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008; 112: 2401-8
32. Shariat SF, Ehdaie B, Rink M et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol 2012; 61: 237-42
33. Zlotta AR. Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform? Eur Urol 2012; 61: 243-4
34. Weingartner K, Ramaswamy A, Bittinger A et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996; 156: 1969-71 (Pubitemid 26378028)
35. Stein JP, Penson DF, Cai J et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007; 177: 876-81; discussion 81-2
36. Bochner BH, Cho D, Herr HW et al. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004; 172: 1286-90 (Pubitemid 39249699)
37. Fang AC, Ahmad AE, Whitson JM et al. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010; 116: 1901-8
38. Dangle PP, Gong MC, Bahnson RR et al. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 2010; 183: 499-503
39. Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 2007; 178: 1218-23; discussion 23-4
40. Abol-Enein H, El-Baz M, Abd El-Hameed MA et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004; 172: 1818-21 (Pubitemid 39363063)
41. Roth B, Wissmeyer MP, Zehnder P et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57: 205-11
42. Retz M, Lehmann J, Szysnik C et al. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol 2004; 45: 314-9 (Pubitemid 38221404)
43. Marin-Aguilera M, Mengual L, Burset M et al. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol 2008; 54: 1363-72